The analysis named the 25 U.S. life science startups most likely to go public, including a Denver-based diabetes treatment startup believed to be worth $2 billion.
Click here to view original post
Click Here to Publish/Feature Your Company or Product News with Biotech Networks
A multi-institutional research project led by immunology researchers from the University of Colorado Anschutz Medical Campus will focus on underlying disease mechanisms of inborn errors of immunity (IEI), which could ultimately help uncover therapies for […]
DENVER, May 15, 2025 /PRNewswire/ — Onus IV Therapy + Longevity is proud to announce its 10-year anniversary, marking a decade of delivering cutting-edge wellness services and empowering thousands of Coloradans to take control of […]
With four days left in the legislative session, business groups, the governor’s office, legislative leadership and trial lawyers announced a compromise they say could avoid bitter battles at the ballot box seeking to alter or […]
Copyright © 2026 Biotech Networks
